Table of contents
Volume 100, Issue 10
Published online 12 May 2009 (1517-1696)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics
Minireviews
Molecular classification of solid tumours: towards pathway-driven therapeutics
C Swanton and C Caldas
Br J Cancer 100: 1517-1522; advance online publication, April 14, 2009; doi:10.1038/sj.bjc.6605031
Targeting HSP90 for cancer therapy
D Mahalingam, R Swords, J S Carew, S T Nawrocki, K Bhalla and F J Giles
Br J Cancer 100: 1523-1529; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605066
Clinical Studies
Positive lymph node retrieval ratio optimises patient staging in colorectal cancer
S J Moug, J D Saldanha, J R McGregor, M Balsitis and R H Diament
Br J Cancer 100: 1530-1533; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605049
Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease
R Mayor, L Casadomé, D Azuara, V Moreno, S J Clark, G Capellà and M A Peinado
Br J Cancer 100: 1534-1539; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605045
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer
A Gaber, M Johansson, U-H Stenman, K Hotakainen, F Pontén, B Glimelius, A Bjartell, K Jirström and H Birgisson
Br J Cancer 100: 1540-1548; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605047
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
M Gusella, A C Frigo, C Bolzonella, R Marinelli, C Barile, A Bononi, G Crepaldi, D Menon, L Stievano, S Toso, F Pasini, E Ferrazzi and R Padrini
Br J Cancer 100: 1549-1557; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605052
The impact of radiotherapy late effects on quality of life in gynaecological cancer patients
C L Barker, J A Routledge, D J J Farnell, R Swindell and S E Davidson
Br J Cancer 100: 1558-1565; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605050
Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group
G Apolone, O Corli, A Caraceni, E Negri, S Deandrea, M Montanari and M T Greco on behalf of the Cancer Pain Outcome Research Study Group (CPOR SG) Investigators
Br J Cancer 100: 1566-1574; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605053
Translational Therapeutics
Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas
P Farace, M Galiè, F Merigo, A Daducci, L Calderan, E Nicolato, A Degrassi, E Pesenti, A Sbarbati and P Marzola
Br J Cancer 100: 1575-1580; advance online publication, April 21, 2009; doi:10.1038/sj.bjc.6605041
Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy
H Xue, C J Field, M B Sawyer, L A Dieleman and V E Baracos
Br J Cancer 100: 1581-1588; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605051
Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-
B-dependent activation of the urokinase plasminogen activator system
S D Killeen, J H Wang, E J Andrews and H P Redmond
Br J Cancer 100: 1589-1602; doi:10.1038/sj.bjc.6604942
Molecular Diagnostics
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
J Nilsson, J Skog, A Nordstrand, V Baranov, L Mincheva-Nilsson, X O Breakefield and A Widmark
Br J Cancer 100: 1603-1607; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605058
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer
P Barboro, E Repaci, A Rubagotti, S Salvi, S Boccardo, B Spina, M Truini, C Introini, P Puppo, N Ferrari, G Carmignani, F Boccardo and C Balbi
Br J Cancer 100: 1608-1616; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605057
Expression of endoglin (CD105) in cervical cancer
H J Zijlmans, G J Fleuren, S Hazelbag, C F Sier, E J Dreef, G G Kenter and A Gorter
Br J Cancer 100: 1617-1626; advance online publication, April 7, 2009; doi:10.1038/sj.bjc.6605009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
K Beiske, S A Burchill, I Y Cheung, E Hiyama, R C Seeger, S L Cohn, A D J Pearson and K K Matthay
Br J Cancer 100: 1627-1637; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605029
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
S Singh, K C Nannuru, A Sadanandam, M L Varney and R K Singh
Br J Cancer 100: 1638-1646; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605055
Activation of Wnt/
-catenin signalling pathway induces chemoresistance to interferon-
/5-fluorouracil combination therapy for hepatocellular carcinoma
T Noda, H Nagano, I Takemasa, S Yoshioka, M Murakami, H Wada, S Kobayashi, S Marubashi, Y Takeda, K Dono, K Umeshita, N Matsuura, K Matsubara, Y Doki, M Mori and M Monden
Br J Cancer 100: 1647-1658; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605064
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
M Talieri, L Li, Y Zheng, D K Alexopoulou, A Soosaipillai, A Scorilas, D Xynopoulos and E P Diamandis
Br J Cancer 100: 1659-1665; advance online publication, April 14, 2009; doi:10.1038/sj.bjc.6605033
Hypoxia-inducible factor-1 and -2 are expressed in most rectal cancers but only hypoxia-inducible factor-1 is associated with prognosis
S Rasheed, A L Harris, P P Tekkis, H Turley, A Silver, P J McDonald, I C Talbot, R Glynne-Jones, J M A Northover and T Guenther
Br J Cancer 100: 1666-1673; doi:10.1038/sj.bjc.6605026
Genetics and Genomics
TGFBR1 variants TGFBR1 * 6A and Int7G24A are not associated with an increased familial colorectal cancer risk
J Skoglund Lundin, J Vandrovcova, B Song, X Zhou, M Zelada-Hedman, B Werelius, R S Houlston and A Lindblom
Br J Cancer 100: 1674-1679; advance online publication, April 28, 2009; doi:10.1038/sj.bjc.6605054
Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer
J Chang-Claude, C B Ambrosone, C Lilla, S Kropp, I Helmbold, D von Fournier, W Haase, M-L Sautter-Bihl, F Wenz, P Schmezer and O Popanda
Br J Cancer 100: 1680-1686; advance online publication, April 14, 2009; doi:10.1038/sj.bjc.6605036
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer
R Shah, P Smith, C Purdie, P Quinlan, L Baker, P Aman, A M Thompson and T Crook
Br J Cancer 100: 1687-1696; doi:10.1038/sj.bjc.6605042
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
